Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

NCT03304639 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

NIH

Sponsor class

Conditions

Advanced Merkel Cell Carcinoma
Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8
Metastatic Merkel Cell Carcinoma
Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
Pathologic Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v8
Pathologic Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v8
Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8

Interventions

BIOLOGICAL: Pembrolizumab
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

National Cancer Institute (NCI)